| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |